Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy
NCT04722133
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
Interventions
DRUG:
HERZUMA+mFOLFOX
Sponsor
Yonsei University